Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Charles SchwabSCHW |
-$350,000 |
 |
Morgan StanleyMS |
-$92,000 |
 |
BNY MellonBK |
$48,000 |
 |
Goldman SachsGS |
-$460,000 |
 |
HSBCHSBC |
-$17,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson | Dec 18, 2025 | Sell | $1K - $15K |
| Julie Johnson | Nov 13, 2025 | Sell | $1K - $15K |
| Val Hoyle | Sep 23, 2025 | Sell | $1K - $15K |
| Julie Johnson | Aug 14, 2025 | Sell | $1K - $15K |
| Julie Johnson | Aug 11, 2025 | Buy | $1K - $15K |
| Julie Johnson | Jul 22, 2025 | Buy | $1K - $15K |
| Valerie Hoyle | May 21, 2025 | Buy | $1K - $15K |
| Jefferson Shreve | May 12, 2025 | Sell | $15K - $50K |
| Rob Bresnahan | Apr 8, 2025 | Buy | $1K - $15K |
| Carol Devine Miller | Mar 10, 2025 | Buy | $1K - $15K |
FAQ - Congress Trading
Julie Johnson sold CME Group shares most recently on December 18, 2025.
Julie Johnson has bought the most CME stock in the last 2 years, with an estimated value of $16,000.
Jefferson Shreve has sold the most CME stock in the last 2 years, with an estimated value of $33,000.
The net value of trades by US politicians for CME Group in the last 2 years is negative, amounting to -$25,000. This suggests that US politicians do not believe in the success of the company for various reasons.
Over the last 2 years, insider transactions for CME Group have been balanced between buying and selling, showing a neutral stance among insiders towards the company's market performance. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
